Targeted inhibition of allergen‐induced histamine production by neutrophils

Histamine is a critical inflammatory mediator in allergic diseases. We showed in a previous work that neutrophils from allergic patients produce histamine in response to allergens to which the patients were sensitized. Here, we investigate the molecular mechanisms involved in this process using peri...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2021-05, Vol.35 (5), p.e21483-n/a
Main Authors: Chacón, Pedro, Vega‐Rioja, Antonio, Doukkali, Bouchra, del Valle Rodríguez, Alberto, Bellido, Virginia, Puente, Yolanda, Alcañiz, Lorena, Rodríguez, David, Palacios, Ricardo, Cornejo‐García, José Antonio, Monteseirín, Javier, Rivas‐Pérez, David
Format: Article
Language:English
Subjects:
allergen immunotherapy
asthma
diamine oxidase
histamine
histidine decarboxylase
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Histamine is a critical inflammatory mediator in allergic diseases. We showed in a previous work that neutrophils from allergic patients produce histamine in response to allergens to which the patients were sensitized. Here, we investigate the molecular mechanisms involved in this process using peripheral blood neutrophils. We challenged these cells in vitro with allergens and analyzed histamine release in the culture supernatants. We also explored the effect of common therapeutic drugs that ameliorate allergic symptoms, as well as allergen‐specific immunotherapy. Additionally, we examined the expression of histidine decarboxylase and diamine oxidase, critical enzymes in the metabolism of histamine, under allergen challenge. We show that allergen‐induced histamine release is dependent on the activation of the phosphoinositide 3‐kinase, mitogen‐activated protein kinase p38, and extracellular signal‐regulated kinase 1/2 signaling pathways. We also found a contribution of the phosphatase calcineurin to lesser extent. Anti‐histamines, glucocorticoids, anti‐M3‐muscarinic receptor antagonists, and mainly β2‐receptor agonists abolished the allergen‐dependent histamine release. Interestingly, allergen‐specific immunotherapy canceled the histamine release through the downregulation of histidine decarboxylase expression. Our observations describe novel molecular mechanisms involved in the allergen‐dependent histamine release by human neutrophils and provide new targets to inhibit histamine production.
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.202001912R